Founded in 1976, Genentech is a leading biotechnology company that pioneers the development of innovative medicines used to treat serious and life-threatening diseases. Headquartered in South San Francisco, California, Genentech combines cutting-edge scientific research and advanced technologies to deliver groundbreaking therapies in oncology, immunology, neuroscience, and other fields. As a member of the Roche Group, the company continues to push the boundaries of medical science with a commitment to improving patients' lives. Recognized for its culture of collaboration and dedication to scientific excellence, Genentech is at the forefront of advancements in personalized healthcare.